[1] |
PODREZ E A, ABU-SOUD H M,HAZEN S L. Myeloperoxidase-generated oxidants and atherosclerosis[J]. Free Radic Biol Med,2000,28(12):1717-1725.
|
[2] |
CARR A C,MYZAK M C,STOCKER R,et al.Myeloperoxidase binds to low-density lipoprotein:potential implications for atherosclerosis[J]. FEBS Lett,2000,487(2):176-180.
|
[3] |
APPLE F S,WU A H,MAIR J,et al.Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome[J]. Clin Chem,2005,51(5):810-824.
|
[4] |
FU X,KASSIM S Y,PARKS W C,et al.Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin(MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase[J]. J Biol Chem,2001,276(44):41279-41287.
|
[5] |
SHABANI F,MCNEIL J,TIPPETT L.The oxidative inactivation of tissue inhibitor of metalloproteinase-1(TIMP-1)by hypochlorous acid(HOCI)is suppressed by anti-rheumatic drugs[J]. Free Radic Res,1998,28(2):115-123.
|
[6] |
ROSS R.Atherosclerosis-an inflammatory disease[J]. N Engl J Med,1999,340(2):115-126.
|
[7] |
NICHOLLS S J,HAZEN S L.Myeloperoxidase and cardiovascular disease[J]. Arterioscler Thromb Vasc Biol,2005,25(6):1102-1111.
|
[8] |
BRENNAN M L,HAZEN S L.Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment[J]. Curr Opin Lipidol,2003,14(4):353-359.
|
[9] |
KOETH R A,HASELDEN V,TANG W H.Myeloperoxidase in cardiovascular disease[J]. Adv Clin Chem,2013,62:1-32.
|
[10] |
LAKSHMI V M,NAUSEEF W M,ZENSER T V.Myeloperoxidase potentiates nitric oxide-mediated nitrosation[J]. J Biol Chem,2005,280(3):1746-1753.
|
[11] |
VITA J A,BRENNAN M L,GOKCE N,et al.Serum myeloperoxidase levels independently predict endothelial dysfunction in humans[J]. Circulation,2004,110(9):1134-1139.
|
[12] |
ABU-SOUD H M,HAZEN S L. Nitric oxide is a physiological substrate for mammalian peroxidases[J]. J Biol Chem,2000,275(48):37524-37532.
|
[13] |
DELPORTE C,VAN ANTWERPEN P,VANHAMME L,et al.Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies[J]. Mediators Inflamm,2013,2013:971579.
|
[14] |
EXNER M,HERMANN M,HOFBAUER R,et al.Thiocyanate catalyzes myeloperoxidase-initiated lipid oxidation in LDL[J]. Free Radic Biol Med,2004,37(2):146-155.
|
[15] |
ZHANG R,BRENNAN M L,SHEN Z,et al.Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation[J]. J Biol Chem,2002,277(48):46116-46122.
|
[16] |
PODREZ E A,SCHMITT D,HOFF H F,et al.Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro[J]. J Clin Invest,1999,103(11):1547-1560.
|
[17] |
ZHANG X,DONG L,WANG Q,et al.The relationship between fasting plasma glucose and MPO in patients with acute coronary syndrome[J]. BMC Cardiovasc Disord,2015,15:93.
|
[18] |
GRANÉR M,TIKKANEN E,RIMPILÄ O,et al. Diagnostic efficacy of myeloperoxidase to identify acute coronary syndrome in subjects with chest pain[J]. Ann Med,2013,45(4):322-327.
|
[19] |
MEHTA M D,MARWAH S A,GHOSH S,et al.A synergistic role of myeloperoxidase and high sensitivity troponin T in the early diagnosis of acute coronary syndrome[J]. Indian J Clin Biochem,2016,31(1):75-80.
|
[20] |
FONG S W,FEW L L,SEE TOO W C,et al. Systemic and coronary levels of CRP,MPO,sCD40L and PIGF in patients with coronary artery disease[J]. BMC Res Notes,2015,8:679.
|
[21] |
VASILJ M,STARCEVIC B,VOLARIC M,et al.Diagnostic value of MPO in patients admitted for suspected acute coronary syndrome-a study of adult in Mostar,Bosnia and Herzegovina[J]. Coll Antropol,2014,38(1):213-217.
|
[22] |
OEMRAWSINGH R M,LENDERINK T,AKKERHUIS K M,et al.Multimarker risk model containing troponin-T,interleukin 10,myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome[J]. Heart,2011,97(13):1061-1066.
|
[23] |
POPE J H,AUFDERHEIDE T P,RUTHAZER R,et al.Missed diagnoses of acute cardiac ischemia in the emergency department[J]. N Engl J Med,2000,342(16):1163-1170.
|
[24] |
SEARLE J,SHIH J,MULLER R,et al.The role of myeloperoxidase(MPO)for prognostic evaluation in sensitive cardiac troponin I negative chest pain patients in the emergency department[J]. Eur Heart J Acute Cardiovasc Care,2013,2(3):203-210.
|
[25] |
GEDIKLI O,KIRIS A,HOSOGLU Y,et al.Serum myeloperoxidase level is associated with heart-type fatty acid-binding protein but not troponin T in patients with chronic heart failure[J]. Med Princ Pract,2015,24(1):42-46.
|
[26] |
CABASSI A,BINNO S M,TEDESCHI S,et al.Myeloperoxidase-related chlorination activity is positively associated with circulating ceruloplasmin in chronic heart failure patients:relationship with neurohormonal,inflammatory,and nutritional parameters[J]. Biomed Res Int,2015,2015:691693.
|
[27] |
REICHLIN T,SOCRATES T,EGLI P,et al.Use of myeloperoxidase for risk stratification in acute heart failure[J]. Clin Chem,2010,56(6):944-951.
|
[28] |
YUNOKI K,NARUKO T,INABA M,et al.Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease[J]. Atherosclerosis,2013,231(2):308-314.
|
[29] |
STEFANESCU A,BRAUN S,NDREPEPA G,et al.Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease[J]. Am Heart J,2008,155(2):356-360.
|
[30] |
WENG K P,HSIEH K S,HUANG S H,et al.Myeloperoxidase genetic polymorphisms and susceptibility to Kawasaki disease in Taiwanese children[J]. J Microbiol Immunol Infect,2016,49(5):788-796.
|
[31] |
LI J,FU Y,ZHAO B,et al.Myeloperoxidase G463A polymorphism and risk of lung cancer[J]. Tumour Biol,2014,35(1):821-829.
|
[32] |
CHEN L,ZHAO S,CHENG G,et al.Meta-analysis of myeloperoxidase gene polymorphism and coronary artery disease susceptibility[J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban,2014,39(3):217-231.
|
[33] |
HOU X,GAO Y,DUAN Y,et al.The association between myeloperoxidase 463G>A polymorphisms and risk of lung cancer in East-Asia population[J]. J Cancer Res Ther,2015,11(Suppl 1):C97-C100.
|
[34] |
NATTER C,POLTERAUER S,PILS S,et al.Association of -463G/A MPO gene polymorphism and risk of cervical intraepithelial neoplasia[J]. Arch Gynecol Obstet,2016,293(4):865-869.
|
[35] |
MEHANNA E T,SALEH S M,GHATTAS M H,et al.Relation of myeloperoxidase-463G/A polymorphism with metabolic syndrome and its component traits in Egyptian women[J]. Arch Physiol Biochem,2015,121(1):13-18.
|
[36] |
NDREPEPA G,BRAUN S,SCHÖMIG A,et al. Impact of therapy with statins,beta-blockers and angiotensin-converting enzyme inhibitors on plasma myeloperoxidase in patients with coronary artery disease[J]. Clin Res Cardiol,2011,100(4):327-333.
|
[37] |
ROBERTS C K,WON D,PRUTHI S,et al.Effect of a short-term diet and exercise intervention on oxidative stress,inflammation,MMP-9,and monocyte chemotactic activity in men with metabolic syndrome factors[J]. J Appl Physiol(1985),2006,100(5):1657-1665.
|
[38] |
CHANG P Y,WU T L,HUNG C C,et al.Development of an ELISA for myeloperoxidase on microplate:normal reference values and effect of temperature on specimen preparation[J]. Clin Chim Acta,2006,373(1-2):158-163.
|